Officials estimate that since early April there had been infected with H1N1 bird flu up to 1 million Americans a lot. Its symptoms, which is similar to the seasonal flu, which may include fever, headache, coughing, sneezing, sore throat, muscle or joint pain for up to one week. Who has been working with a considerable number of infected people also reported diarrhea and vomiting. Antiviral drugs such as Tamiflu and Relenza have been found effective treatment and reduce the duration of the disease, from one or two days in general. However, in order to play the biggest role, it must in the management of symptoms 12 to 48 hours. This may be a problem, taking into account the traditional identification of cell culture, the virus may take several days, and rapid detection tests can provide results within 30 minutes or less are not sure H1N1 virus, more than half the time, according to a new government report .
The U.S. Centers for Disease Control (CDC) for research and testing has proved to contain the use of laboratory testing, from the three companies: Binax Inc., Becton, Dickinson Company, and three Quidel’s influenza virus clinical samples Quidel best performance of the test and found that 69 percent of infections. In flow cytometry, Dickinson trial testing 49-fold, Binax test found that 40 percent. All tests found that seasonal influenza H1N1 viruses better than that. “These findings suggest that, despite the positive (rapid detection test) results can be made to deal with decisions, negative results do not exclude new influenza (H1N1) virus infection,” the author writes with.
These findings are not entirely unexpected. A clinical virology to a recent study found that a test found that only 10 percent of the H1N1 virus infection, and the second found that only 40%. In the “absence of a ton of rapid detection of influenza” can pick a more advanced laboratory culture, long?????Christensen said that in microbiology, virology and molecular diagnostics, director of the north shore of Long Island Jewish Medical System in Lake Success, while in New York, in a letter in June New England Journal of Medicine, the U.S. Navy researchers have described the Quidel tests of sensitivity, and noted that they found that only half of the infections picked up a more sensitive technology.
However, the test makers say their product is helpful, if used properly. Clinical and regulatory affairs senior vice president of Quidel Corporation John Tamerius said Quidel’s QuickVue influenza virus A-and B-type influenza antigen detection tests can be found 80 percent of infections, if the specimen from the management of the nose to do swabs taken directly to the self-correct, and if this test is given at an early stage disease, when more of the viral infection process. “When used properly these tests, performance is very, very good,” Tamerius said.
Last week, the Center for Disease Control and Prevention updated guidance, requiring careful examination to rely on fear of negative readings may prevent antiviral treated patients, especially those high-risk, such as pregnant women and those with asthma or other conditions of the basic medical health-care providers such as heart disease and diabetes.
